Sonendo Inc. (SONX)
2.76
-0.24 (-8.00%)
At close: Jan 14, 2025, 12:02 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
undefined% (undefined)
| Bid | n/a |
| Market Cap | 1.15M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -78.25 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 2,000 |
| Avg. Volume (20D) | 3,484 |
| Open | 2.99 |
| Previous Close | 3.00 |
| Day's Range | 2.76 - 3.33 |
| 52-Week Range | 1.00 - 5.00 |
| Beta | undefined |
About SONX
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; a...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 29, 2021
Employees 200
Stock Exchange NYSE
Ticker Symbol SONX
Website https://sonendo.com
Analyst Forecast
According to 1 analyst ratings, the average rating for SONX stock is "Hold." The 12-month stock price forecast is $50, which is an increase of 1711.59% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Sonendo Inc. is scheduled to release its earnings on Mar 10, 2025,
during market hours.
Analysts project revenue of $8.65M, reflecting a -26.02% YoY shrinking and earnings per share of -16, making a -33.33% decrease YoY.
Analysts project revenue of $8.65M, reflecting a -26.02% YoY shrinking and earnings per share of -16, making a -33.33% decrease YoY.
